1. Home
  2. DXPE vs SLS Comparison

DXPE vs SLS Comparison

Compare DXPE & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DXP Enterprises Inc.

DXPE

DXP Enterprises Inc.

N/A

Current Price

$184.14

Market Cap

3.0B

Sector

Industrials

ML Signal

N/A

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

N/A

Current Price

$11.53

Market Cap

2.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DXPE
SLS
Founded
1908
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.7B
IPO Year
1998
2007

Fundamental Metrics

Financial Performance
Metric
DXPE
SLS
Price
$184.14
$11.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$154.00
$10.00
AVG Volume (30 Days)
74.3K
7.2M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
27.25
50.00
EPS
2.98
N/A
Revenue
$1,247,043,000.00
N/A
Revenue This Year
$9.31
N/A
Revenue Next Year
$7.85
$110.98
P/E Ratio
$61.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$84.04
$1.39
52 Week High
$208.00
$15.88

Technical Indicators

Market Signals
Indicator
DXPE
SLS
Relative Strength Index (RSI) 49.75 42.35
Support Level $180.88 $10.85
Resistance Level $183.91 $15.77
Average True Range (ATR) 5.22 1.05
MACD -1.28 -0.36
Stochastic Oscillator 37.76 18.55

Price Performance

Historical Comparison
DXPE
SLS

About DXPE DXP Enterprises Inc.

DXP Enterprises Inc is engaged in the business of distributing maintenance, repair and operating (MRO) products, equipment and service to customers in various end markets, including general industrial, energy, food & beverage, chemical, transportation, water and wastewater. The company operates through three business segments: Service Centers, Innovative Pumping Solutions and Supply Chain Services. The majority of revenue is derived from the Service Centers segment, which provides a wide range of MRO products in the rotating equipment, bearing, power transmission, hose, fluid power, metal working, fastener, industrial supply, safety products and safety services categories. Geographically, it generates the maximum revenue from the United States.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: